The Library
Induction of intracellular heat-shock protein 72 prevents the development of vascular smooth muscle cell calcification
Tools
Tools
Tools
Lu, T.-S., Lim, Kenneth Jia-En, Molostvov, Guerman, Yang, Y.-C., Yiao, S.-Y., Zehnder, Daniel and Hsiao, L.-L. (2012) Induction of intracellular heat-shock protein 72 prevents the development of vascular smooth muscle cell calcification. Cardiovascular Research, 96 (3). pp. 524-532. doi:10.1093/cvr/cvs278 ISSN 0008-6363.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1093/cvr/cvs278
Abstract
Aims Vascular calcification (VC) is a significant contributor to cardiovascular mortality in patients with chronic kidney disease (CKD) and coronary artery disease (CAD). Osteo/chondrocytic transformation and simultaneous dedifferentiation of smooth muscle cells (SMCs) are important in the pathogenesis of VC. Heat-shock protein 72 (HSP72) is a cardioprotective inducible heat-shock protein that functions as a molecular chaperone. However, its role in the development of accelerated vascular dysfunction and calcification is largely unexplored.
Methods and results We describe for the first time marked reduction in HSP72 expression in arteries from patients with CKD and CAD, compared with healthy controls, in vivo. Induction of HSP72 by heat-shock treatment (HST) significantly prevented the development of calcification of human aortic smooth muscle cells (HA-SMCs), in vitro. These anti-calcific effects were abolished following treatment with both quercetin, an HST inhibitor, and HSP72 siRNA knockdown. Induction of HSP72 suppressed Cbfa-1-dependent osteo/chondrocytic transformation and stabilized SMC contractile phenotype through the myocardin–serum response factor (SRF) pathway. Co-immunoprecipitation studies demonstrated physical association between SRF and HSP72. Furthermore, organ culture of arteries from CKD and CAD patients showed that these arteries retained their ability to induce HSP72 following HST, despite initially reduced expression.
Conclusion Our study shows for the first time that intracellular HSP72 may function as a central regulator of molecular pathways involved in the development of VC. We suggest treatment strategies that up-regulate HSP72 as a new approach to inhibit VC.
| Item Type: | Journal Article | ||||
|---|---|---|---|---|---|
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School | ||||
| Journal or Publication Title: | Cardiovascular Research | ||||
| Publisher: | Oxford University Press | ||||
| ISSN: | 0008-6363 | ||||
| Official Date: | 1 December 2012 | ||||
| Dates: |
|
||||
| Volume: | 96 | ||||
| Number: | 3 | ||||
| Page Range: | pp. 524-532 | ||||
| DOI: | 10.1093/cvr/cvs278 | ||||
| Status: | Peer Reviewed | ||||
| Publication Status: | Published | ||||
| Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
